Safety and efficacy of cisplatin plus paclitaxel in patients with uterine cervical cancer which has risk factors for recurrence
Not Applicable
- Conditions
- terine cervical cancer
- Registration Number
- JPRN-UMIN000035856
- Lead Sponsor
- Department of Obstetrics and Gynecology Osaka City Iniversity Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 75
Inclusion Criteria
Not provided
Exclusion Criteria
(1) who has severe infection after operation. (2)who has severe complicarion. (3)who has other cancer. (4)who has interstitial pneumonia or pulmonary fibrosis. (5)who have ascirtes or pleural infussion which need treatment. (6)who has the administration contraindication to cisplatin or paclitaxel. (7)who is severe allergic to drug. (8)who is considered inappropriate to this study by attending doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method two years disease free survival rate
- Secondary Outcome Measures
Name Time Method